Attendance at this event is complimentary.

The event is primarily aimed at innovators, biotechs, and policymakers across the life sciences ecosystem with an interest in exploring practical applications, as well as the legal and ethical considerations and strategies for responsible AI adoption.

All registrations are subject to review to ensure they align with the intended audience for the event. Where a registration does not meet these criteria, it may not be accepted. You will be informed if your registration has been cancelled within 2 working days of registering online for the event.

From accelerating drug discovery and enabling precision medicine to improving diagnostics, clinical trials, and healthcare operations, AI is reshaping the future of life sciences. But with new technology comes new risk. Alongside questions of adoption and implementation, organisations must also consider key legal and governance issues, including contracts, intellectual property, and data protection when using AI tools. How can life science companies unlock AI’s potential while effectively mitigating uncertainty and risk?

The format will include a panel discussion and audience segment where you can help shape the agenda by sharing the AI challenges and opportunities that matter most to you.

Agenda:
08:30 – 09:00 Arrival, Networking and Refreshments
09:00 – 10:15 Panel Insights and Interactive Discussion
Moderator: Aline Charpentier, Science Strategy and Innovation Lead, Wellcome Genome Campus
Panellists: Sunil Jindal, Regional Director, Freeman Clarke; Matthew Clark, Cyber Director, Partners&; Rachel Bradley, Partner – IP/IT/Commercial, Penningtons Manches Cooper
10:15 – 11:00 Networking Continues and Close